Chapel Hill, NC10 Active Studies

Osteogenesis Imperfecta Clinical Trials in Chapel Hill, NC

Find 10 actively recruiting osteogenesis imperfecta clinical trials in Chapel Hill, NC. Connect with local research sites and explore new treatment options.

10
Active Trials
10
Sponsors
2,798
Enrolling

Recruiting Osteogenesis Imperfecta Studies in Chapel Hill

About Osteogenesis Imperfecta Clinical Trials in Chapel Hill

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 10 osteogenesis imperfecta clinical trials recruiting participants in Chapel Hill, NC. These studies are seeking a combined 2,798 participants. Research is being sponsored by Duke University, Stichting Hemato-Oncologie voor Volwassenen Nederland, University of Florida and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Chapel Hill — FAQ

Are there osteogenesis imperfecta clinical trials in Chapel Hill?

Yes, there are 10 osteogenesis imperfecta clinical trials currently recruiting in Chapel Hill, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chapel Hill?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.

Are clinical trials in Chapel Hill free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 10 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated August 27, 2026 from ClinicalTrials.gov